Bausch lomb crystalens hd accommodating iol Anonymous sex chatroom
The colors of everything are so much brighter and the improved sharpness and clarity of my vision are very noticeable,” This testimonial clarifies the deep impact that Crystalens accomplishes on the patient’s quality of life. The normal crystalline lens has the ability to change its shape and diameter to allow us to see perfectly far objects as well as near objects and anything in between.
Unfortunately, this amazing property is lost gradually as we grow older. This condition resembles the normal physiological aging of the crystalline lens. At this age people start to lose some of their up-close vision and start wearing reading glasses to compensate for that.
Bausch & Lomb has recently introduced their newest intraocular lens implant (IOL), the Crystalens® Aspheric Optic lens.
The Crystalens® AO is the newest addition to the Crystalens line of IOL's.
ALISO VIEJO, Calif., June 30 /PRNewswire/ -- Bausch & Lomb announced today that it has received approval from the Food and Drug Administration (FDA) to market the Crystalens HD(TM) in the United States.
Crystalens accommodating intraocular lens (IOL) was first approved by the FDA in November 2003.
The Crystalens AO has zero spherical aberration so it also improves the depth of field.
The new lens provides clear vision at far distances, arm's length (intermediate) distances and up close for reading smaller print.
These resemble the most advanced treatment option available to cataract patients.
Amongst the testimonials for the Crystalens are such as below: “I didn’t realize what I had been missing before I had my Crystalens surgery.
The Crystalens HD is the fourth generation of the only FDA approved accommodating lens.
The surface of the Crystalens HD has been shaped to enhance the depth of focus with a proprietary optical modification.
The Crystalens family of lenses are the only FDA approved accommodating IOL's.